No Picture
Trading Ideas

U.S. auto safety agency to investigate fatal Tesla crash in California

The fatal Dec. 29 crash of a Tesla Inc vehicle in Southern California will be investigated by the U.S. government’s auto safety regulator, the agency said on Tuesday. The U.S. National Highway Traffic Safety Administration (NHTSA) said earlier this month it had opened an investigation into a 12th Tesla crash that may be tied to the vehicle’s advanced Autopilot driver assistance system after a Tesla Model 3 rear-ended a parked police car in Connecticut. NHTSA did not say if autopilot was suspected in Sunday’s crash in Gardena in Los Angeles county. …read more […]

No Picture
Trading Ideas

U.S. holiday returns surge with booming e-commerce

Jan. 2 is the busiest day for holiday returns in the United States. U.S. shoppers return more packages than their peers around the globe, spurred by free shipping on orders and returns – costly perks that squeeze retailer profits. About 10% of goods sold in the United States go back to retailers every year, resulting in roughly $369 billion in lost sales, according to a 2018 report from Appriss Retail and National Retail Federation. …read more […]

No Picture
Trading Ideas

Nasdaq Caps a $7 Trillion Decade With Its Best Rally In 10 Years

(Bloomberg) — In a decade of extreme wealth creation in markets, few assets did more to enrich investors than stocks in the Nasdaq 100 Index. Their combined value jumped by more than $7 trillion, ending with the best year since the bull run began.Powered by a near-doubling in Apple Inc. and gains exceeding 50% in Microsoft Corp. and Facebook Inc., the tech-heavy gauge surged 38% over the past 12 months, the biggest increase since 2009.Technology companies needed 15 years to recover from the dot-com crash, coming full circle in 2015. Since then, they’ve doubled again. But for all the rampant …read more […]

No Picture
Trading Ideas

Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors. Nearly all of the price increases will be below 10%, and around half of them are in the range of 4 to 6%, 3 Axis co-founder Eric Pachman said. More price increases are expected to be announced later this week, which could affect the median and range. …read more […]